150 related articles for article (PubMed ID: 26308910)
1. Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.
Shao JJ; Peng Y; Wang LM; Wang JK; Chen X
DNA Cell Biol; 2015 Nov; 34(11):669-76. PubMed ID: 26308910
[TBL] [Abstract][Full Text] [Related]
2. K6PC-5, a novel sphingosine kinase 1 (SphK1) activator, alleviates dexamethasone-induced damages to osteoblasts through activating SphK1-Akt signaling.
Ji F; Mao L; Liu Y; Cao X; Xie Y; Wang S; Fei H
Biochem Biophys Res Commun; 2015 Mar; 458(3):568-575. PubMed ID: 25680461
[TBL] [Abstract][Full Text] [Related]
3. Activation of Akt by SC79 protects myocardiocytes from oxygen and glucose deprivation (OGD)/re-oxygenation.
Zheng K; Zhang Q; Lin G; Li Y; Sheng Z; Wang J; Chen L; Lu HH
Oncotarget; 2017 Feb; 8(9):14978-14987. PubMed ID: 28122357
[TBL] [Abstract][Full Text] [Related]
4. K6PC-5 Activates SphK1-Nrf2 Signaling to Protect Neuronal Cells from Oxygen Glucose Deprivation/Re-Oxygenation.
Liu H; Zhang Z; Xu M; Xu R; Wang Z; Di G
Cell Physiol Biochem; 2018; 51(4):1908-1920. PubMed ID: 30504702
[TBL] [Abstract][Full Text] [Related]
5. K6PC-5, a direct activator of sphingosine kinase 1, promotes epidermal differentiation through intracellular Ca2+ signaling.
Hong JH; Youm JK; Kwon MJ; Park BD; Lee YM; Lee SI; Shin DM; Lee SH
J Invest Dermatol; 2008 Sep; 128(9):2166-78. PubMed ID: 18385762
[TBL] [Abstract][Full Text] [Related]
6. Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating of Akt-Nrf2 signaling.
Zheng K; Sheng Z; Li Y; Lu H
Biochem Biophys Res Commun; 2014 Aug; 451(1):79-85. PubMed ID: 25063033
[TBL] [Abstract][Full Text] [Related]
7. Ciliary Neurotrophic Factor (CNTF) Protects Myocardial Cells from Oxygen Glucose Deprivation (OGD)/Re-Oxygenation via Activation of Akt-Nrf2 Signaling.
Zheng K; Zhang Q; Sheng Z; Li Y; Lu HH
Cell Physiol Biochem; 2018; 51(4):1852-1862. PubMed ID: 30504707
[TBL] [Abstract][Full Text] [Related]
8. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
9. K6PC-5, a sphingosine kinase activator, induces anti-aging effects in intrinsically aged skin through intracellular Ca2+ signaling.
Youm JK; Jo H; Hong JH; Shin DM; Kwon MJ; Jeong SK; Park BD; Choi EH; Lee SH
J Dermatol Sci; 2008 Aug; 51(2):89-102. PubMed ID: 18420384
[TBL] [Abstract][Full Text] [Related]
10. MiR-124 promotes ischemia-reperfusion induced cardiomyocyte apoptosis by targeting sphingosine kinase 1.
Liu BF; Chen Q; Zhang M; Zhu YK
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7049-7058. PubMed ID: 31486506
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis.
Pchejetski D; Kunduzova O; Dayon A; Calise D; Seguelas MH; Leducq N; Seif I; Parini A; Cuvillier O
Circ Res; 2007 Jan; 100(1):41-9. PubMed ID: 17158340
[TBL] [Abstract][Full Text] [Related]
12. K6PC-5, a novel sphingosine kinase activator, improves long-term ultraviolet light-exposed aged murine skin.
Park HY; Youm JK; Kwon MJ; Park BD; Lee SH; Choi EH
Exp Dermatol; 2008 Oct; 17(10):829-36. PubMed ID: 18341573
[TBL] [Abstract][Full Text] [Related]
13. The sphingosine kinase inhibitor SKI-V suppresses cervical cancer cell growth.
Zhang Y; Cheng L; Shi X; Song Y; Chen XY; Chen MB; Yao J; Zhang ZQ; Cai S
Int J Biol Sci; 2022; 18(7):2994-3005. PubMed ID: 35541904
[TBL] [Abstract][Full Text] [Related]
14. Low-concentration of perifosine surprisingly protects cardiomyocytes from oxygen glucose deprivation.
Zheng K; Lu H; Sheng Z; Li Y; Xu B
Biochem Biophys Res Commun; 2016 Jan; 469(3):753-60. PubMed ID: 26686418
[TBL] [Abstract][Full Text] [Related]
15. Plant Natural Product Formononetin Protects Rat Cardiomyocyte H9c2 Cells against Oxygen Glucose Deprivation and Reoxygenation via Inhibiting ROS Formation and Promoting GSK-3β Phosphorylation.
Cheng Y; Xia Z; Han Y; Rong J
Oxid Med Cell Longev; 2016; 2016():2060874. PubMed ID: 27034732
[TBL] [Abstract][Full Text] [Related]
16. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
[TBL] [Abstract][Full Text] [Related]
17. Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation.
Gao H; Gao MQ; Peng JJ; Han M; Liu KL; Han YT
Acta Pharmacol Sin; 2017 Dec; 38(12):1618-1631. PubMed ID: 29119970
[TBL] [Abstract][Full Text] [Related]
18. Silibinin activates AMP-activated protein kinase to protect neuronal cells from oxygen and glucose deprivation-re-oxygenation.
Xie Z; Ding SQ; Shen YF
Biochem Biophys Res Commun; 2014 Nov; 454(2):313-9. PubMed ID: 25450395
[TBL] [Abstract][Full Text] [Related]
19. Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth.
Xue Y; Jiang K; Ou L; Shen M; Yang Y; Lu J; Xu W
Cell Death Dis; 2022 Jul; 13(7):602. PubMed ID: 35831279
[TBL] [Abstract][Full Text] [Related]
20. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
